Immunotherapy of hepatic metastases
The CIML is proud to announce that Prof. Eric Vivier is one of the recipients of the highly competitive and generously funded Synergy Grant from the European Research Council (ERC). Together with Valeria Fumagalli (San Raffaele Hospital, Italy), Georg Gasteiger (Max Planck Research Group at the University of Würzburg), Florent Ginhoux (Gustave Roussy Cancer Campus, France), they will explore new avenues for immunotherapy of liver metastases – a condition that affects approximately half of all cancer patients.
This ERC Synergy Grant is the fourth European Research Council grant won by Prof. Eric Vivier's team. They had already won two ERC Advanced Grants in 2010 and 2015, as well as an ERC Proof of Concept in 2019.
